265% growth in unit sales through direct-to-consumer channels, 97% overall revenue growth vs. Q2 2021 SAN FRANCISCO, CA – August 15, 2022 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended June 30, 2022. Jennifer Ernst, CEO of Tivic Health […]
SAN FRANCISCO, June 16, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that for the second consecutive year ClearUP® Sinus Pain Relief has received Global Health & Pharma’s 2022 award for Most Innovative Sinus Relief Solution. ClearUP is a small handheld device […]
SAN FRANCISCO, CA — June 13, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the Annual General Meeting of Shareholders will be held on Tuesday, June 14, 2022, at 10:00 a.m., Pacific Daylight Time. The Company has adopted a virtual format for […]
SAN FRANCISCO, May 25, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced survey findings revealing that seasonal allergies impact job performance, commuting, and the ability to enjoy outdoor activities. A randomized survey of 2,000 U.S. allergy sufferers* was conducted last month by […]
77% year-over-year growth in unit sales direct-to-consumer; 219% increase in gross profit. SAN FRANCISCO–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended March 31, 2022. “I am pleased that our strategy to grow direct-to-consumer sales […]
SAN FRANCISCO, CA – May 9, 2022 – Jennifer Ernst, CEO of Tivic Health® Systems, Inc. (Nasdaq: TIVC), is an invited speaker at FORTUNE Brainstorm Health and will participate on the panel Driving Digital Health: Where Wearables Are Headed Next. The session will take place on May 11 and panelists will include Robert Ford, chairman […]
SAN FRANCISCO, April 14, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”) a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that financial results for the fourth quarter of 2021 and the year-end shareholder update will take place via conference call on Tuesday, April 19, 2022, […]
Veronica Cai Appointed to Chief Financial Officer; Ryan Sabia Promoted to Chief Operating Officer and Sanjay Ahuja Joined as Senior Vice President, Quality Assurance & Regulatory Affairs SAN FRANCISCO, April 5, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, […]
SAN FRANCISCO, February 7, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced that ClearUP® Sinus Pain Relief was named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine (GHP). The GHP Technology Awards celebrate businesses and professionals who have made exceptional […]
Growing recognition of Bioelectronic Medicine as an important new therapeutic category SAN FRANCISCO, January 31, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, was one of two companies featured in the ABC News story “New Bioelectronic Technologies Could Signal the Future of Medicine.” Will Carr reported on […]
